Intercept Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoi…

Biotechnology
US, New York [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ICPT's Analysis
CIK: 1270073 CUSIP: 45845P108 ISIN: US45845P1084 LEI: - UEI: -
Secondary Listings
ICPT has no secondary listings inside our databases.